King of Prussia, PA – August 24, 2016 – Greenphire, the global leader in clinical payment solutions, has been named to the Inc. 5000 list of fastest-growing private companies in America for the fourth year in a row.
Based on the organization’s three-year growth rate of 190%, Greenphire ranks 1,949 on the list of an elite group of organizations that have demonstrated consistently high growth from 2012 through 2015. The complete 2016 Inc. 5000 list can be found at http://www.inc.com/inc5000.
“There is an industry-wide effort underway to improve clinical trial workflow operations, putting an increased demand on eliminating time-consuming manual processes, such as processing payments to sites and patients,” said Jim Murphy, CEO of Greenphire. “This demand coupled with our team’s commitment to delivering innovative payment solutions has fueled our staggering growth. We are honored to once again be recognized alongside other transformative businesses.”
Greenphire leads the industry in innovating and optimizing clinical trial payments with an exclusive focus on clinical trial payment solutions. Providing a better way to pay patients and sites around the world, Greenphire is the partner of choice to more than 500 clients, including 9 of the top 10 pharmaceutical companies.
Greenphire will be recognized at the 35th Annual Inc. 5000 Conference and Gala, which will be held October 18- 20, 2016 at the JW Marriott Hill Country in San Antonio. Featured keynote speakers include Tony Robbins, Marvell Technology’s Weili Dai and New Belgium Brewing’s Kim Jordan. For details, visit www.inc5000conference.com.
About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.
